Whitebox Advisors’s Trinity Biotech TRIB Stock Holding History

Whitebox Advisors’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-110,849	Closed	-$9.71M	–	437
2014 Q4	$9.71M	Sell	110,849 -30,533	-22%	-$2.63M	0.39%	57
2014 Q3	$12.9M	Buy	141,382 +8,290	+6%	+$898K	0.5%	47
2014 Q2	$15.3M	Buy	133,092 +42,239	+46%	+$5.01M	0.6%	44
2014 Q1	$11M	Buy	90,853 +29,371	+48%	+$3.85M	0.47%	46
2013 Q4	$7.73M	Buy	61,482 +3,650	+6%	+$438K	0.34%	48
2013 Q3	$6.29M	Buy	57,832 +20,000	+53%	+$1.95M	0.33%	51
2013 Q2	$3.19M	Buy	+37,832	New	+$3.14M	0.17%	68

Other funds holding TRIB

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

AAM

ACK Asset Management Greenwich, Connecticut $801M AUM 60.42% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

TAM

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

RCMC

RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return

Whitebox Advisors's TRIB Position: Q1 2015 in Review

Whitebox Advisors sold out of Trinity Biotech (TRIB) in Q1 2015, closing a stake of 110,849 shares — an estimated $9.71M sold.

Whitebox Advisors first reported a position in TRIB in Q2 2013 and held it in 7 quarters. The position peaked at $15.3M in Q2 2014. 89 funds tracked by Wall St. Rank hold TRIB as of Q1 2015.

Whitebox Advisors reported no remaining Trinity Biotech position as of Q1 2015 after selling out during the quarter.
Whitebox Advisors sold 110,849 Trinity Biotech shares in Q1 2015, an estimated $9.71M.
Whitebox Advisors first reported a position in Trinity Biotech in Q2 2013 and held it in 7 quarters.
Whitebox Advisors's Trinity Biotech position peaked at $15.3M in Q2 2014.
89 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2015.

Based on Whitebox Advisors's 13F filing for Q1 2015, filed 12 May 2015.